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Cell size homeostasis is a conserved attribute in many eukaryotic species involving a tight regulation between the
processes of growth and proliferation. In budding yeast S. cerevisiae, growth to a “critical cell size” must be achieved
before a cell can progress past START and commit to cell division. Numerous studies have shown that progression
past START is actively regulated by cell size control genes, many of which have implications in cell cycle control
and cancer. Two initial screens identified genes that strongly modulate cell size in yeast. Since a second generation
yeast gene knockout collection has been generated, we screened an additional 779 yeast knockouts containing 435
new ORFs (~7% of the yeast genome) to supplement previous cell size screens. Upon completion, 10 new strong
size mutants were identified: nine in log-phase cells and one in saturation-phase cells, and 97% of the yeast
genome has now been screened for cell size mutations. The majority of the logarithmic phase size mutants have
functions associated with translation further implicating the central role of growth control in the cell division
process. Genetic analyses suggest ECM9 is directly associated with the START transition. Further, the small (whi)
mutants mrpl49Δ and cbs1Δ are dependent on CLN3 for cell size effects. In depth analyses of new size mutants
may facilitate a better understanding of the processes that govern cell size homeostasis.
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Cell size homeostasis is physiologically important to
nearly all organisms. This is evident from the uniformity
and conservation of size within a cell lineage amongst
the individuals of a species from bacteria to man [1].
Moreover, studies in flies, mice and humans indicate the
presence of an organ size checkpoint during develop-
mental stages [2]. To ensure a population of cells that
maintain a constant average cell size, it is essential that
cells coordinate the processes of growth, which increases
cell size, and cell division, which reduces cell size [3].
Irregularities in these processes affect fitness and function
[4]. In the budding yeast S. cerevisiae, coordination of
growth and division occurs at START, the point of com-
mitment to the cell cycle [5,6] which is equivalent to the
Restriction point in mammalian cells [7]. At START, a cell
transits, essentially irreversibly, from G1- to S-phase. Early* Correspondence: brandt.schneider@ttuhsc.edu
1Department of Cell Biology and Biochemistry, Texas Tech University Health
Sciences Center, 3601 4th St Rm. 5C119, Lubbock, TX 79430, USA
Full list of author information is available at the end of the article
© 2012 Dungrawala et al.; licensee BioMed Ce
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumgenetic analyses of START revealed that blocking cell
growth prevents cell cycle progression [5]. However, the
converse is not true [5]. For example, the discovery of cell
division cycle (CDC) genes, a class of essential genes
involved in cell cycle control, established that cell growth
is a continuous process that proceeds unabated even when
cell cycle progression is halted [8]. The end result is the
production of abnormally large cells [5]. Thus, the
mechanisms that regulate the cell cycle can have a pro-
found impact on cell growth and vice versa.
Physiological studies in yeast and mammalian cells
suggest that cells undergo exponential growth through-
out the cell cycle [4,9-12]. Since exponential growth is
inherently tied to cell size (e.g. larger cells grow faster
than smaller cells), some type of “size sensing” mecha-
nism is required for cell size homeostasis [4,13,14].
While the mechanism remains somewhat obscure, evi-
dence suggests that in yeast commitment to division is
linked to cell size [4,13,14]. In yeast, cells must attain a
certain “critical cell size” before commitment across
START [5,15], but while there are hints of a “size sensing”ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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“critical cell size” phenomenon exists in mammalian cells
[9,16-20]. Nonetheless, the investigation of cell size mutants
has provided mechanistic clues to START regulation in
yeast. For example, some of the very first cell size mutants
in yeast implicated cyclins and cyclin dependent kinases
(Cdks) in the control of cell size [21-23]. These included
mutants that stabilized cyclins (e.g. CLN3-1) in budding
yeast or promoted the activity of Cdks in fission yeast (e.g.
wee1) [22-25]. Subsequently, genome-wide genetic screens
systematically identified yeast mutants with altered cell size
phenotypes [26,27]. These studies led to the identification
of genes which play a strong role in regulating cell cycle
progression past START [26,27]. Mutants which alter CLN
expression strongly alter cell size phenotypes. For example,
deletion of the START inhibitor WHI5 results in a popula-
tion of cells with a small size phenotype [26,27]. Conversely,
deletion of CLN3 or BCK2, upstream activators of CLN ex-
pression cause a cell cycle delay thus inducing a large cell
size phenotype [28,29]. Deleting both CLN3 and BCK2
results in inviability, but cln3Δbck2Δ cells can be partially
rescued by inducing CLN2 expression ectopically or by de-
leting WHI5 [29-32]. Deletion of the transcription factors
that regulate CLN transcription (e.g. SWI4 and SWI6) also
results in a large cell size phenotype [33]. In contrast, early
CLN expression advances cell cycle progression and
reduces cell size [31,32]. Thus, many genes involved in cell
size control appear to interface with the mechanisms that
regulate progression past START in budding yeast [26].
Cell size is sensitive to the conditions of external envi-
ronment. Size homeostasis mechanisms exist during nu-
tritional up shift, that are distinctly different from those
involved in steady-state environment conditions [34].
Cells cultured in poor nutrients grow slower and are
smaller compared to isogenic populations cultured in
rich environmental conditions [35-38]. As such, ribo-
some biogenesis has been strongly implicated in mo-
dulating critical cell size for yeast cells at START
[37,39,40]. Furthermore, genes implicated in the process
of ribosome biogenesis are also size mutants [26,27]. In-
deed, a recent report has established multiple genes that
function in protein synthesis as strong regulators of
START [39]. Interestingly, the majority of mutants that
altered cell cycle progression did not affect cell size and
vice versa [39]. Despite these observations, evidence sug-
gests that carbon source modulates size via Clns [41,42],
and that growth rates are potentially linked to CLN
thresholds for START entry [38,43,44]. These results
warrant further investigation into the mechanistic regu-
lation of cell division by genes affecting growth and cell
size which would help elucidate the relationship between
nutrient transduction signals and cell cycle entry. Also,
nutrient sensing pathways play an important role in
modulating the aging process in various model systems[45]. Thus, it would be beneficial in elucidating the co-
ordination between growth and proliferation under di-
fferent nutritional environments.
The basic mechanisms of cell cycle control are well
conserved evolutionarily. Not only is gene function
highly conserved, but the products of these genes also
appear to have the same fundamental role in the regula-
tion of cell size from yeast to man [1]. Indeed, an analo-
gous system for G1-S transition exists between yeast and
mammals wherein Cln3, SBF and Whi5 play similar roles
to that of cyclin D, E2F and RB respectively [46-48].
Moreover, like their yeast homologs, the expression of
cyclin D, E2F and RB influences cell size homeostasis. For
example, cells lacking cyclin D are larger than normal
while cells over-expressing cyclin D are smaller than nor-
mal [49-53]. Moreover, like whi5Δ strains, cells lacking
pRb are smaller than normal [54-56]. Conversely, loss of
E2F function increases cell size [57]. The extent of evolu-
tionary conservation of cell cycle genes between yeast and
mammals signifies the importance of cell size control
studies in S. cerevisiae. Although the genetic pathways
involved in cell cycle control are well established, the
mechanisms whereby these same pathways modulate cell
size are not well understood. Therefore, the elucidation of
gene function in yeast is likely to provide valuable insights
into mammalian cell biology.
For this study, we screened the entire yeast knock-out
collection version 2 (YKOv2) containing 779 ORF dele-
tions for cell size mutants. From this screen, 10 new
strong size mutants were identified: nine from logarith-
mic and one from saturation cultures. Like previous
screens, the majority of the size mutants are involved in
some aspect of the translation process. This further
implicates the control of translation in the mechanisms
that coordinate growth and proliferation, and comple-
tion of this screen will provide a valuable database for
researchers interested in dissecting the process of cell
size control.
Results
Cell size screen analysis
In the two previous studies, 5958 diploid deletion strains
were screened for cell size mutants in saturated cultures
[27] while 4812 haploid deletion strains were analyzed in
log-phase cultures [26]. In total, ~90% of the 6607 cu-
rrently annotated yeast ORFs were evaluated for cell size
defects [26,27,58]. To expand upon these results, the
second generation yeast gene deletion strain collection
(YKOv2) was obtained from OPEN Biosystems. These
included all the additions/updates (e.g. new ORF annota-
tions that were added to the existing database) and co-
rrections to the previous collection [59,60]. Thus, a total
of 779 diploid strains were sized in both logarithmic and
saturated cultures to identify new cell size mutants
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435 new ORF deletions (235 essentials and 200 non-
essentials constituting ~7% of the genome) which have
not been sized previously (Additional file 1: Table S1).
Consequently, after this current screen, ~97% of the
available yeast ORFs have now been screened for cell
size mutants.
The size curves of budding yeast cultures are usually
not normal distributions (Figure 1A), but rather are
positively skewed to the right (Figure 1B). Therefore, we
collected and compared average mean, median and
mode size values as previously described [27]. To ensure
the proper identification of the size mutants, outliers
were selected as potential size mutants on the basis of
being +/− 2 standard deviations from average mean, me-
dian and mode values (see Materials and Methods). This
methodology was applied to both logarithmic and satu-
ration phase readings (Additional file 2: Figure S1).
Evaluation of mean cell sizes from the entire population
of logarithmic and saturated cultures revealed a distribu-
tion curve that was nearly identical to our previous
study (Additional file 3: Figure S2 and data not shown).Figure 1 Size distribution curves for budding yeasts. (A) Curve depicts
values. (B) Curve depicts a size distribution curve for budding yeasts obtain
curves are usually skewed to the right where the mode is often the smalle
daughter cells. Also, due to the asymmetric nature of cell division and expo
the median. (C) Coulter counter curves for representative size mutants in th
mutant (ctr9Δ).In addition, screenings identified 10 new deletion strains
as potential size mutants: 9 in logarithmic phase and 1
in saturation phase. In total in log phase, seven gene
deletions (rpl36bΔ, mrpl49Δ, cbs1Δ, rpl42aΔ, rom2Δ,
rpl16bΔ, and yjr114wΔ) produced abnormally small
(whi) cells while two gene deletions (ctr9Δ and ecm9Δ)
increased cell size (uge mutants) in log phase (Table 1).
Only one gene deletion, ctr9Δ, was found to significantly
alter size in saturation and produced abnormally large
cells (Table 1). Representative cell size plots for a whi
mutant, rpl36bΔ and an uge mutant, ctr9Δ are shown in
Figure 1C.
Internal controls within the second generation dele-
tion collection allowed us to test the reproducibility of
previous cell size measurements. For example, of the
779 deletion strains in YKOv2, 144 were newly con-
structed deletions of previously knocked-out genes [60].
Importantly, sizing of these new deletions led to the
identification of four new size mutants (cbs1Δ, rpl16bΔ,
rom2Δ, rpl42aΔ) suggesting that the original deletions
might not have completely removed the function from
these ORFs. However, 132/140 (94.2%) of the remaininga normal distribution curve with similar mean, median and mode
ed in logarithmic phase. Unlike normal distributions, yeast cell size
st value, since ~50% of the population is comprised of newly born
nential nature of cell growth, the mean value tends to be larger than
e logarithmic phase: whi mutant (rpl36bΔ), wild-type (WT) and uge
Table 1 Summary of cell size mutants
Gene ORF Cell size (fL) Budding % G1% S/G2/M% Human homolog E-value Function
LOGARITHMIC
WT 101.7 56 38 62
whi rpl36bΔ YPL249C-A 66.0** 40 62 38 RPL36 2e-26 Translation
mrpl49Δ YJL096W 66.8** 45 59 41 RFT1 0.16 Translation
cbs1Δ YDL069C 71.2** 43 45 55 TLR5 0.28 Translation
rpl42aΔ YNL162W 73.9** 46 50 50 RPL36AL 2e-51 Translation
YJR114W 77.1* 54 53 47 - – Unknown
rom2Δ YLR371W 80.2** 60 55 45 ARHGEF3 3e-16 GEP for Rho
rpl16bΔ# YNL069C 83.5* 52 44 56 L13a 5e-76 Translation
uge ecm9Δ YKR004C-A 135.9* 62 37 63 KCNS2 0.060 Cell Wall Organization
ctr9Δ YOL145C 128.5* 36 33 67 CTR9 2e-48 Transcription
SATURATED
WT 49.7 3 96 4
uge ctr9Δ YOL145C 76.8* 11 93 7 CTR9 2e-48 Transcription
A summary of cell size mutants, grouped together under logarithmic and saturated conditions, is shown. Data includes the gene, open reading frame (ORF) of the
gene, mean cell size in femtoliters (fL), budding index values, cell cycle distribution in logarithmic phase obtained by FACS, human homolog, E-values and cellular
function associated with each gene. Statistical differences in mean cell size values were calculated using unpaired t-test (**p<0.0001, *p<0.05). # All genetic strains
are homozygous diploids except for rpl16bΔ which is a heterozygous diploid. Thus, rpl16bΔ is a haploinsufficient cell size mutant. Note that YJR114W is a dubious
ORF.
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expected size phenotype (Additional file 1: Table S1).
These included 10 previously reported cell size mutants
[26,27] (Additional file 1: Table S1). Of the eight dele-
tions that failed to reproduce the expected size pheno-
type, two were very close to being significantly larger
(Additional file 1: Table S1). Thus, the true reproducibi-
lity likely ranges from 94-96% indicative of the robust-
ness of the approach.
Mutants alter daughter birth size and “critical cell size”
Analyses of Coulter Counter data only provides size data
for the entire population. To evaluate how the size of in-
dividual cells vary, we used time lapse photography of
single cells over 10–12 hours as previously described
[61]. Examination and sizing of individual cells revealed
that all seven whi mutants produced virgin daughter
cells that are statistically smaller (p<0.0001) than wild
type virgin daughter cells (Figure 2A). In addition, dele-
tion of CTR9 and ECM9 produced statistically larger
than normal virgin daughter cells (p<0.05) (Figure 2A).
In yeast, cells commit to division after attaining a cer-
tain “critical cell size”. To observe changes in the “cri-
tical cell size” at START, time-lapse microscopy was also
used to study the pattern of cell division over time for
the new size mutants. For experimental purposes, size at
bud emergence was measured for daughter and mother
cells and plotted against % budded. START usually refers
to the point at which 50% of the cell population has
budded. For all the seven whi mutants, the size of virgin
daughters at START was significantly smaller (p<0.0001)than in wild type cells (Figure 2B and 2D). In addition,
for all seven whi mutants, mother cells progressed past
START at a significantly smaller size compared to wild
type mother cells (Figure 3A and C). For the large cell
mutants, the situation was exactly the reverse; virgin
daughters were born large (Figure 2A), and both daugh-
ters (Figure 2C and 2D) and mothers (Figure 3B and C)
progressed past START at a cell size that was signifi-
cantly larger (p<0.05) than in wild type cells. These
results suggest that the newly identified cell size mutants
alter the “critical cell size” at which commitment to cell
division occurs.
Cell cycle effects
Many of the known cell size control genes also strongly
affect cell cycle progression [22,29,31,32,62,63]. Thus,
flow cytometry and the budding index of cultures were
used to assess cell cycle distributions in the newly identi-
fied cell size mutants (Table 1). In addition, we were able
to directly measure the length of the unbudded (G1-
phase) and budded (S-G2-M-phases) segments of the
cell cycle in all of the cell size mutants from the time
lapse studies of single cells (Table 2). From these data,
several trends emerged. First, overall cell cycle time was
increased in all mutants regardless of their size (Table 2).
Second, a considerable increase in the length of G1-
phase was predominantly responsible for the increase in
cell cycle times (Table 2). Third, while G1-phase was
increased in all mutants, the degree to which it was
affected was extremely variable: ranging from a 0–7.6








Figure 2 Mutants alter birth size and “critical cell size” for
daughters. (A) Box plot (refer Materials and Methods) represents
the cell size distributions (in microns) at which daughter cells were
born. Average size: whi mutants mrpl49Δ=4.2, rpl42aΔ=4.5,
yjr114wΔ=4.5, rom2Δ=4.6, cbs1Δ=4.6, rpl36bΔ=4.6, rpl16bΔ=5,
WT=5.4 and uge mutants ctr9Δ=5.5, ecm9Δ=6.1 (**p<0.0001,
*p<0.05). (B) Plot represents % budded virgin daughters vs. cell size
(microns): the whi mutants undergo division at an average “critical
cell size” (defined by 50% budded) that is smaller than that of the
wild type (mrpl49Δ= 5.0, rpl42aΔ= 5.1, rom2Δ= 5.1, yjr114wΔ=5.3,
rpl36bΔ= 5.4, rpl16bΔ=5.5, cbs1Δ= 5.6, WT= 5.8). (C) Plot represents
% budded virgin daughters vs. cell size (microns): large cell (uge)
mutants undergo division at an average “critical cell size” larger than
that of the wild type (WT= 5.8, ctr9Δ= 6.5, ecm9Δ= 6.6). (D) Box plot
represents distributions (n=30-40) of daughter cell sizes at which
they bud (**p<0.0001, * p=0.0008). Statistical differences were
determined by Mann Whitney Test with p=0.05 as cutoff value.
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shortest G1-phases had, in general, the highest budding
indices (Tables 1 and 2). In this respect, only one whi
mutant, rom2Δ, increased the budding percentage com-
pared to that of wild type which would suggest a puta-
tive inhibitory role of ROM2 in the START transition. In
contrast, the majority of the whi mutants had an
increased accumulation of cells in G1-phase compared
to the wild type. Such a pattern is characteristic of cells
with a slow growth phenotype [35] in which cells display
a small size phenotype with extended periods of G1
phase [64].From the uge mutants identified, ctr9Δ strongly reduces
the budding index values to that of the wild type while
ecm9Δ moderately increased budding in log phase
(Table 1). In contrast, the uge mutant ctr9Δ in saturated
phase increased the percentage of budded cells and con-
comitantly decreased the number of cells in G1-phase
(Table 1) suggesting that these mutants impeded the abi-
lity of cells to exit the cell cycle.
In order to establish any potential hierarchical role of
the newly identified cell size mutants in START regulation,
double deletion combinations for individual mutants were
created with the START activator CLN3; and the START
inhibitor, WHI5. In wild type cells, deletion of CLN3
results in a cell cycle delay thereby inducing a large cell
size phenotype [26,27]. We found that deletion of
YJR114W, RPL36B, ROM2 and RPL42A yielded an inter-
mediate size phenotype in combination with deletion of
CLN3 (Table 3). However, deletion of MRPL49 and CBS1
did not reduce the size of cln3Δ cells. These results suggest
that the small size phenotype of the mrpl49Δ and cbs1Δ
whi mutants is dependent upon CLN3. With respect to
the uge mutants, both ctr9Δcln3Δ and ecm9Δcln3Δ double
mutants were larger than either haploid alone indicating a
synergistic effect (Table 3 and Additional file 1: Table S1).
On the other hand, combination of whi5Δ with all the whi
mutants (except rpl42aΔ) resulted in double mutants that
were smaller than either haploid alone indicative of a syn-
ergistic effect. With respect to the uge mutants,
ctr9Δwhi5Δ double mutant displayed an intermediate size
phenotype while ecm9Δwhi5Δ double mutant was small.
Since whi5Δ was epistatic to ecm9Δ, the large size pheno-
type of ecm9Δ mutant is most likely dependent upon
WHI5 (Table 3 and Additional file 1: Table S1).
Finally, over-expression studies were carried out to de-
termine whether any of the newly identified cell size
mutants could function as activators or inhibitors of
START. Over-expression of ECM9 resulted in a strong
reduction of cell size distribution (Table 4). Furthermore,
the increased budding index values along with a higher
percentage in S/G2/M phase suggests that Ecm9 pro-
motes START (Table 4). On the other hand, over-
expression of CTR9 increased the budding index values
without a concomitant decrease in cell size of the cul-
ture. Counter-intuitively, over-expression of six whi
mutants also reduced cell size (Table 4). Evidence indi-
cated that over-expression of these whi mutants led to
decreased proliferation rates in the majority of cases
(data not shown) and some G1-phase delays (Table 4).
Cell growth and cell size homeostasis
Examination of the known function of the new cell size
mutants suggests that reduced protein synthesis and
overall growth rate may correlate with decreased cell
size. For example, 5 of the 7 whi mutants isolated are
Figure 3 Mutants alter “critical cell size” at START for mothers. (A) The % of budded mother cells vs. cell size (microns) is plotted: whi
mutants undergo division at a “critical cell size” smaller than that of the wild type (rpl42aΔ= 5.5, mrpl49Δ= 5.5, rom2Δ= 5.6, rpl36bΔ= 5.7,
yjr114wΔ= 5.7, rpl16bΔ= 5.9, cbs1Δ= 6.0, WT= 6.3). (B) The % of budded mother cells vs. cell size (microns) is plotted: large cell (uge) mutants
undergo division at a “critical cell size” larger than that of the wild type (WT= 6.3, ecm9Δ= 7.0, ctr9Δ= 7.1). (C) Box plots represent size
distributions (n=35-45) of mother cell populations at which they bud (**p<0.0001). Statistical differences were determined by Mann Whitney Test
with p=0.05 as cutoff value.
Table 2 Summary of cell cycle effects
Daughter Mother Overall
Strain Birth size B1 size G1 (min) B2 size CT B1 size CT1 B2 size CT2 B3 size G1 (min) CT RGR
WT 5.4 5.8 32 6.0 83 6.3 75 6.4 74 6.4 4 77 100%
mrpl49Δ 4.2 5.1 172 5.2 167 5.5 140 5.6 154 5.7 30 154 51%
rpl42aΔ 4.4 5.1 94 5.4 131 5.5 97 5.5 115 5.6 8 114 58%
yjr114wΔ 4.5 5.4 136 5.5 183 5.8 136 5.9 137 6.0 25 152 67%
rpl36bΔ 4.6 5.4 131 5.6 158 5.7 143 5.8 139 5.8 24 147 67%
rom2Δ 4.6 5.1 89 5.3 135 5.6 115 5.6 111 5.7 4 120 64%
cbs1Δ 4.6 5.6 141 5.9 208 6.0 129 6.1 150 6.2 26 162 69%
rpl16bΔ 5.0 5.5 47 5.8 124 5.9 94 6.0 100 6.1 6 106 83%
ctr9Δ 5.5 6.5 130 6.8 153 7.1 110 7.2 145 7.3 20 136 116%
ecm9Δ 6.1 6.6 41 7.0 127 7.0 114 7.2 107 7.3 8 116 155%
Data gathered from microscopic analyses of >30 individual cells over a 6–10 hour time course is presented. Cell diameters are in microns. In each case, the birth
diameter of daughter cells is shown. In addition, the size at which cells bud for the first time (B1) and subsequent buds (B2, etc.) are also provided. The length of
G1-phase is directly measured as the time cells remain unbudded. Cycle time (CT) is measured from the time a cell first buds until its subsequent bud. Overall
cycle time (CT) is shown as the average of one daughter CT and the first two mother cell cycle times. The relative growth rate (RGR) is a measure of the total cell
volume produced per generation and is determined by calculating the change in volume of mother cells in each generation added, to the volume of daughter
cells produced. For volume calculations, cells are assumed to resemble spheres and the formula 4/3πr3 is used. Wild type (WT) cells are set to 100% and all
mutants are subsequently normalized to this value.
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Genetic epistasis analysis with cln3Δ and whi5Δ. Double deletion combinations
were created for the new logarithmic phase size mutants with cln3Δ (uge
mutant) and whi5Δ (whi mutant). Haploids were analyzed for the cell size
phenotype. Table represents the pair wise genetic relationships: Intermediate
(+), epistatic (↑) (the gene pointed to by the arrow masked the size phenotype
of the other deletion), synergistic (•), no effect (−). Epistasis was operationally
defined as an average cell size for double mutants within +/− 5% of size of
either single mutant. Synergistic effects refer to combinatorial cell sizes that
are either substantially larger or smaller than each single mutant. Intermediate
refers to combinatorial cell sizes that lie between the size of each single
mutant. Since RPL16B is an essential gene, it could not be analyzed in these
studies. Size values with statistics can be found in Additional file 1: Table S1.
Dungrawala et al. Cell Division 2012, 7:24 Page 7 of 13
http://www.celldiv.com/content/7/1/24involved in general protein translation (Table 1). Three
of these mutants, rpl36bΔ, rpl42aΔ and rpl16bΔ, asso-
ciate with the large ribosomal subunit in the ribosome
assembly process [65] while MRPL49 and CBS1 are
involved in mitochondrial protein synthesis [66]. Since
previous screens for cell size mutants have revealed that
a significant number of whi mutants whose gene pro-
ducts normally function in protein synthesis or ribosome
biogenesis [26,27], the growth rate of individual cells
was determined from time course data. By measuring
the rate of cell size increase in mother cells and the size
of buds produced, we were able to determine theTable 4 Over-expression analyses
WT + Mean N SE G1% S/G2/M% Budding index
Empty Vector 78 11 1 56.99 40.56 44.3
ECM9 62** 11 1 52.21 47.79 60.3
CTR9 80 14 1 54 46 65.7
MRPL49 68** 11 2 52.38 47.62 51.9
YJR114W 68* 13 2 72.53 27.47 44.4
RPL42A 68** 13 1 52.24 47.76 57.7
RPL16B 72** 13 1 44.31 55.69 62.3
CBS1 69* 14 2 72.64 24.46 45.7
RPL36B 73 6 4 59.31 40.09 41.6
Over-expression analysis in wild type cells. This table illustrates the effects of
over-expressing the new size mutant genes in wild type yeast cells. Data
includes the average cell size from logarithmic cultures, number of replicates,
standard error, % of cells in G1 and S/G2/M phases as determined by flow
cytometry, and the budding index values. Statistical differences in mean cell
size values were calculated using unpaired t-test (**p<0.0001, *p<0.0051). All
analyses were carried out in -Ura Raf/Gal media using GAL-inducible vectors.
Vector alone (pB63) was used as a control. Note: We were unable to generate
a GAL-ROM2 inducible vector.average relative growth rate for both whi and uge
mutants in each generation. In doing so, we found all
seven whi mutants had average growth rates that were
17-49% less than wild type cells (Table 2). In contrast,
the average growth rate was higher in both large cell
mutants (Table 2). These results suggest that growth
rates correlate well with cell size phenotypes.
Discussion
Identification and impact of new cell size mutants
Cell size homeostasis is attained by a highly intricate re-
lationship between growth and proliferation. Previous
studies suggest that growth is rate-limiting for commit-
ment to cell division such that cells must attain a “cri-
tical cell size” prior to START transition [5,6,15]. To
better understand the global mechanism behind cell size
control, two systematic genome-wide genetic screens
were carried out ten years ago to detect cell size mutants
from both log phase and saturated cultures [26,27].
Many of the identified cell size genes are directly asso-
ciated with START and are linked to CLNs [27]. Signifi-
cantly, the yeast ortholog of the pRB tumor suppressor
was identified in the previous screens [26,27]. In
addition, key regulators of cell growth and ribosome bio-
genesis (e.g. Sfp1 and Sch9) were shown to be strong
whi mutants [26]. Such analyses proved to be highly
valuable in the detailed characterization of cell size ma-
chinery. Since the original screens were conducted, a
second generation yeast deletion collection has been
constructed containing hundreds of new knockout
strains and re-created deletions (n.b. most of these dele-
tions were remade to correct quality control issues such
as a partial rather than complete ORF deletion). The ob-
jective of this study was to expand the genome-wide sys-
tematic screen concept by evaluating the ~800 newly
made ORF deletions for size mutants. In so doing, 9 cell
size mutants were identified in the logarithmic phase
cultures and 1 cell size mutant was identified in satu-
rated cultures. Of the ~140 ORF deletions that were re-
made, >94% of the strains reproduced the original
phenotype including both strong whi (e.g. sch9Δ) and
large cell phenotypes (e.g. ccr4Δ). Importantly, screening
of the re-made ORF deletions yielded four new size
mutants, supporting the notion that some deletions in
the original collection did in fact retain some gene func-
tion. In total, seven new whi and two new large cell
mutants were identified, and after completion of this
work, ~97% of the yeast genome has been now screened
for cell size mutants.
In the previous screens, many of the whi mutants
identified involved the deletion of genes that function in
ribosome biogenesis and translation [26,27]. Of note, 5
of the 7 newly identified whi mutants are involved in the
general process of translation supporting the hypothesis
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growth and is a prerequisite for normal cell cycle pro-
gression [39,40]. One whi mutant, yjr114wΔ, has an un-
known function; however its phenotype may be due to
loss of function of the overlapping RSM7 ORF. The
RSM7 gene encodes a mitochondrial ribosomal subunit
that when deleted also yields a small cell phenotype [26].
A final whi mutant, rom2Δ, is also clearly involved in the
regulation of cell growth. Rom2 is a GEF protein which
interacts with the TOR signaling pathway in sensing nutri-
ents from the external environment [67]. TOR is impli-
cated to play a major role in the overall synthesis of
proteins and inhibiting its activity strongly affects cell size
phenotypes [68,69]. Also, Rom2 activates Rho1 GTPase
and rho1ts mutants have been reported to reduce the cell
volume of both mother cells at G1/S transition and
daughter cells at birth [70]. Interestingly, premature CLN2
expression had been observed in rho1-3 mutants and may
help explain why rom2Δ mutants display a small size with
higher budding index. Amongst the uge mutants isolated,
CTR9 plays a direct role in the transcription of CLNs
through association with the Paf1p complex [71] and
ecm9Δ strains exhibit alterations in cell surface biosyn-
thesis due to defects in β 1,3-glucan synthesis [72]. Signifi-
cantly, 8 of the 9 newly identified log phase mutants have
putative human homologs (Table 1) suggesting that cell
size control may be evolutionary conserved.
Initial investigations of the newly identified cell size
mutants reveal that all of the genes identified impact cell
size by altering cell growth rates. Herein, we report that
critical cell size at START is reduced in 7/7 whi mutants
in both daughter and mother cells while cell growth is
also decreased in all whi mutants. Similarly, critical cell
size at START is increased in both large cell mutants
while the rate of cell growth is clearly elevated in both
ecm9Δ and ctr9Δ cells. Indeed, elegant work done by
Jorgensen et al. elucidated a potential link between ribo-
some biogenesis, cell growth, and START which may be
predominantly responsible for the observed cell size
defects [37], and a potential connection between newly
identified size mutants and this work is discussed below.
A comparison between current results and the out-
come of the previous two systematic cell size screens
reveals striking similarities. First, as previously observed,
considerably more size mutants were identified from log
phase as compared to saturated cultures [26,27]. Second,
most size mutants identified in log phase were not also
detected as size mutants in saturated cultures [26,27].
The reason for these observations is not clear at this
time but does indicate that different mechanisms impact
cell size in log phase as compared to saturated cultures.
Finally, the frequency of size mutants detected was very
similar and with 97% of the genome screened, it is clear
that ~6% of the yeast genome is involved in log phasecell size control as opposed to largely different subset of
genes (only ~1% of the genome) that modulates cell size
in saturation.
At the crossroads: cell size regulation and cell cycle
progression
One of the primary goals of systematic genetic size
screens was to identify genes that regulate START. For
example, in budding yeast, START is dependent on the
activity of the G1-phase cyclin CLN3 and its cyclin-
dependent kinase Cdc28 [28,73-75]. CLN3 can regulate
the rate of accumulation of CLN1/CLN2 and alter the
“critical cell size” at START [22,23,76]. Deletion of CLN3
results in delayed accumulation of CLN1/CLN2 causing
the cells to enter cell division at a much larger cell vol-
ume. G1-phase cyclins CLN1/CLN2 dramatically alter
the “critical cell size” and genes which regulate their
transcription have been isolated [22,29,31,32,62,77,78].
Since the role of CLN3 and WHI5 in cell cycle commit-
ment has been well characterized in yeast in addition to
the function of their orthologs in higher eukaryotes [47],
we wanted to examine the role of newly identified size
mutants with START regulation. To accomplish this, we
created double mutants between all newly isolated size
mutants with either the deletion of an inhibitor (e.g.
whi5Δ) or an activator (e.g. cln3Δ) of START. In so
doing, we found that all of the whi mutants, except
rpl42aΔ, had a synergistic effect on cell size when com-
bined with whi5Δ (i.e. double mutants were smaller than
single mutants). Most likely, the size effects in these whi
mutants are mediated through a pathway which is inde-
pendent of WHI5. This result infers the existence of an
additional inhibitor to START. A parallel inhibitor to
WHI5 has been isolated [47], but its relationship with
the newly identified whi mutants is not known. These
results are intriguing in light that the yeast counterparts
of the mammalian p16 and p21 cyclin dependent inhibi-
tors have not yet been identified. Most of the new whi
mutants when combined with cln3Δ produced inter-
mediate size phenotypes; however, the large cell pheno-
type of cln3Δ was epistatic to mrpl49Δ and cbs1Δ
suggesting that these genes function upstream of Cln3.
The large cell size of ctr9Δ mutant is partially
dependent on the activity of WHI5 since double mutants
display additive effects. While CTR9 (Cln Three Requir-
ing) was first identified in a screen for mutants which
required a functioning copy of CLN3 for viability [29],
unlike previous studies [71], we find that cln3Δctr9Δ
mutants are viable albeit slowly dividing very large cells.
This result is likely due to different strain backgrounds.
On the other hand, over-expressing CTR9 did not cause
cell size changes but increased the budding index of the
population. G1-phase cyclins regulate bud emergence in
budding yeasts and localization of CLN2 in the
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though CTR9 is proposed to have a direct role in CLN2
transcription, it is somewhat surprising that the budding
index of cells increases but cell size does not decrease.
However, deletion of WHI5 in ecm9Δ mutants results in
very small cells. These results suggest that Ecm9 func-
tions upstream of Whi5 and may regulate START by
modulating Whi5 activity. Like cln3Δctr9Δ mutants,
cln3Δecm9Δ cells are also slowly dividing very large cells
indicating a general delay in progression past START in
ecm9Δ mutants. Indeed, over-expression of ECM9 resulted
in a dramatic reduction in cell size as well as a strong de-
crease in the percent of unbudded G1-phase cells suppor-
ting the notion that ECM9 directly promotes progression
past START.
Over-expression of Clns prematurely promotes cell
cycle progression. The end result is the production of a
population of small cells with a smaller percentage of
cells in G1-phase. Since most cell size mutants appear to
interact directly or indirectly with the START machinery
(e.g. CLN transcription is induced at a smaller than nor-
mal size in whi mutants and vice versa), the logical
assumption is that most whi mutants would advance cell
cycle progression and thereby reduce the percentage of
cells in G1-phase. Conversely, large cell mutants might
be expected to delay cell cycle progression and thereby
increase the percent of G1-phase cells. This concept was
recently investigated on a genomic-wide scale. Strikingly,
Hoose et al. found virtually no correlation between cell
size mutants and cell cycle distributions [39]. For ex-
ample, the majority of cells showing a dramatically
increased or decreased percent of G1-phase cells were
not cell size mutants [39]. Moreover, the majority of cell
size mutants failed to display altered cell cycle distribu-
tions [39]. Our current results largely corroborate these
findings. The apparent disconnect between cell size regu-
lation and cell cycle progression was reinforced by our
over-expression studies. While over-expression of 7/8 of
our cell size mutants reduced cell size, over-expression of
only 2/7 of these genes dramatically altered cell cycle dis-
tributions, which stands in contrast to another study
where changes in cell cycle progression were shown to be
predominantly due to gain of function alterations [81].
Thus, despite the fact that most whi mutants appear to
advance the timing of CLN transcription, they do not
appear to advance START. The reasons and mechanisms
behind this disconnect warrants considerably more
investigation.
Future perspectives: the slow growth conundrum and a
role for cell size in lifespan regulation?
Evidence suggests that a minimal threshold level of Clns
links cell size to START [38]. In this respect, decreasing
or delaying Cln expression concomitantly slows cellcycle progression to produce abnormally large cells.
Therefore, precise coordination between growth and
proliferation is indispensable for cell size homeostasis.
Since Clns are inherently and constitutively highly un-
stable proteins [82,83], steady state Cln levels would
seem to be an excellent measure of the synthetic ca-
pacity of a cell and thereby provide a means to link cell
growth to cell division [4,13,14,44]. As expected, Cln
levels are low in slowly growing cells. However, counter-
intuitively, slowly growing cells require considerably
lower levels of Cln to progress past START [38]. Con-
versely, rapidly growing cells require high levels of Cln
to bud [38]. The reasons for these observations are still
not known, but a thorough investigation of the relation-
ship between cell size mutants and the regulation of Cln
expression and abundance may provide some clarity to
this conundrum. Another possibility is that the rate of
protein synthesis is the major determinant of cell size.
Dissection of the relationship between cell size mutants,
Cln expression, and cell cycle progression will be a key
step in the elucidation of this issue.
Finally, recent studies have demonstrated that cell size
may be relevant to the rate at which yeast cells age [61].
For example, many of the size mutants exhibit lifespan
phenotypes dependent on the size at birth, i.e. small cells
have an extended lifespan compared to cells that are big
in size [61]. A similar correlation was obtained with size
mutants obtained from this screen. rpl42aΔ, a whi mu-
tant, had an extended lifespan compared to the wild type
[61]. Moreover, two other whi mutants, rom2Δ and
rpl16bΔ, identified in this screen are also reported to
have a prolonged lifespan [84,85]. Although not all
mutants that affect cell size have a lifespan phenotype,
the identification of new size mutants will aid in the
continued investigation into the relationship between
size and replicative lifespan.
Conclusions
Proper coordination between cell growth and proliferation
is essential for normal propagation, development and di-
fferentiation. Multiple studies have outlined the signifi-
cance of such coordination in cell size homeostasis. To
understand the mechanisms of cell size control, two gen-
ome wide screens had been carried out to identify cell size
mutants. Many genes from these screens have now been
established in START regulation. To complete the initial
screen and identify previously unknown cell size genes,
nearly 800 new diploid strains were sized in logarithmic
and saturation phase. Ten new strong cell size mutants
were thus identified. Nearly all of the new whi mutants
function in the translation process thus further supporting
the integral role of growth in cell cycle commitment. Ge-
netic analyses suggest that CLN3 is required to mediate
the size effects in mrpl49Δ and cbs1Δ small mutants.
Dungrawala et al. Cell Division 2012, 7:24 Page 10 of 13
http://www.celldiv.com/content/7/1/24Finally, ECM9 was found to be strongly associated with
START. After completion of this study, ~97% of the yeast
genome has now been screened for cell size mutants. The
consistency of the type and function of the size mutants
identified here reaffirms the robustness of genome wide
screen approaches and augments the current and valuable
database of cell size control genes.
Materials and methods
Cell size analysis
YKOv2, containing the homozygous and heterozygous
diploid S. cerevisiae deletion strain sets, were obtained
from OPEN BIOSYSTEMS. To assay cell size in satu-
ration, five μl of each strain was spotted onto 96 grid
points on 2% YPD plates and incubated at 30°C for 3 days.
A small amount of each colony was suspended in 500μl of
sterile water. Subsequently, ten μl of this dilution was re-
suspended in 10ml of Isoton II (Beckman-Coulter), and
cell size was determined using the Z2 Coulter Counter
Channelyzer (Beckman-Coulter). For logarithmic phase
cell size readings, YPD cultures containing 1–3 × 106
cells/ml were grown to a density of 1-4 × 107 cells/ml, and
cell size was measured as discussed above. The geometric
mean, median and mode values were recorded for 767
strains in the logarithmic phase and 772 strains in the sa-
turation phase (Additional file 1: Table S1). For statistical
analysis, outliers (+/− 2 standard deviations for all 3 para-
meters; mean, median and mode) were identified as cell
size mutants. To ensure stringency, this selection was a-
pplied to data obtained from homozygous, heterozygous,
and combined data (homozygous + heterozygous) for all
the deletion strains (Additional file 1: Table S1). Using this
approach, 32 deletion strains were initially identified as
outliers. Of these, 10 strains had already been mentioned
as size mutants, namely mrpl36Δ, mrc1Δ, bub3Δ, sch9Δ,
ydr417cΔ, ccr4Δ, bcm2Δ, pop2Δ, ydr433wΔ and bud22Δ.
From the remaining strains, ten significantly reproduced
their size phenotypes after at least three independent mea-
surements (Additional file 1: Table S1). PCR amplification
of the unique barcodes was carried out to confirm the ab-
sence of the genes in the newly identified size mutants
(data not shown).
Cell cycle analysis
Cells from logarithmic phase and saturated cultures
were harvested and fixed in ethanol overnight at 4°C.
Cells were then re-suspended in 50mM sodium citrate,
washed and re-suspended again in the same buffer, trea-
ted with RNAse A (final concentration= 0.25mg/ml) for
1 hour at 50°C followed with Proteinase K (final concen-
tration= 0.5mg/ml) for 1 hour at 50°C. Cells were then
stained with Propidium Iodide solution (final concentra-
tion= 16mg/ml) and cell cycle distributions were ana-
lyzed using the Epics XL (Beckman-Coulter) flowcytometer. Microscopic measurements of > 30 individual
cells were used to calculate cell cycle time (CT) defined
as the time at which a cell first budded to the time at
which the cell gave rise to the subsequent bud. The
overall Cycle Time (CT) was calculated by averaging two
mother cell CTs with one daughter cell CT (Table 2).
Budding index values were calculated using five μl of the
same samples. A minimum of 200 yeast cells were
observed microscopically using a phase contrast micro-
scope (Zeiss AxioLab) with a 40X objective. The number
of budded and unbudded cells was recorded, and the bu-
dding index values were calculated. BLAST software from
the National Center for Biotechnology Information
(NCBI) was used to identify conserved human homologs.
Microscopic analysis of cell size
Time-lapse photomicroscopy of > 30 individual cells was
used to determine virgin daughter birth size and the
“critical cell size” at which the size mutants enter di-
vision as described previously [61]. Subsequently, the
percent of budded cells was plotted as a function of cell
size. Box plots illustrate the distribution of cell sizes for
the respective deletion strains. The rectangle includes
the range of sizes spanning the first quartile to the third
quartile. The horizontal band within the box represents
the median value while the whiskers on the top and bo-
ttom represent the maximum and minimum values of
the range respectively. Mann Whitney statistical tests
(GraphPadInStat Version 3.10) were used to evaluate the
significance of cell size differences.
Genetic analyses
Double mutants for epistasis analyses were obtained by
mating MAT alpha cln3 (KanMX::Leu2) and whi5
(KanMX::Leu2) haploids with MAT a cell size mutants
(confirmed by Coulter counter and PCR analyses). At
least 2 individual colonies for each double mutant was
sized in the logarithmic phase (as described above) and
the average calculated as shown in Additional file 1:
Table S1. PCR amplification of the unique barcodes was
carried out to confirm the respective gene deletions. For
over-expression analyses, GAL constructs were created
using the pYES-DEST52 Gateway Vector System (Invi-
trogen). Primers for ORF amplification were designed as
per the guidelines provided by Invitrogen Life Technolo-
gies pENTR Directional TOPO Cloning Kits (Version
E). A PCR reaction typically included 100ng DNA tem-
plate, 2-5μl of Pfu Turbo DNA Polymerase (Stratagene),
100pm of each primer, 8μl of 10X Pfu buffer and 10μl
25mM dNTPs. Standard PCR cycling conditions were:
(A) 2 min at 95°C for denaturation, (B) 30 sec at 95°C
for denaturation, (C) 30 sec at 50º-55°C for annealing,
(D) 1–3 min at 72°C for extension and (E) 5 min at 72°C
as the final extension step, with steps (B)-(D) steps
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excised, from a 1% agarose gel with 0.5μg/ml of eth-
idium bromide, with the help of QIAEX kits (QIAGEN,
Valencia, CA). Cloning procedures for integration into
the pYES-DEST52 gateway vector was followed as per
Invitrogen instructions. For over-expression of CTR9,
GAL1-CTR9 vector was obtained from Thermo Scien-
tific Open Biosystems Yeast ORF Collection with
BG1805 as the backbone vector. Due to the large size of
ROM2 (~4Kb), cloning of its ORF was not successful.
All GAL over-expression vectors were confirmed by re-
striction digestion. Transformation of yeast was carried
out as described previously [86] using -URA as a selec-
table marker. Subsequently, three individual colonies for
each were then cultured overnight in -Ura Raf/Gal
media (1% Raffinose + 1% Galactose) and the samples
were sized in the logarithmic phase. Simultaneously,
samples were isolated to calculate the budding index
and perform flow cytometry to determine the cell cycle
distribution. Rescue experiments were carried out in the
respective deletion strains to confirm ORF functionality
of over-expression plasmids.
Additional files
Additional file 1: Table S1. The tabs represent the following data.
Hom. LOG: Average mean, median and mode values for the sizing of
299 homozygous diploid strains in the logarithmic phase. Het. LOG:
Average mean, median and mode values for the sizing of 468
heterozygous diploid strains in the logarithmic phase. Hom. SAT:
Average mean, median and mode values for the sizing of 303
homozygous diploid strains in the saturation phase. Het. SAT: Average
mean, median and mode values for the sizing of 469 heterozygous
diploid strains in the saturation phase. (Hom + Het) LOG: Average mean,
median and mode values for the sizing of 767 diploid strains in the
logarithmic phase (299 homozygous diploids + 468 heterozygous
diploids). (Hom + Het) SAT: Average mean, median and mode values for
the sizing of 772 diploid strains in the saturation phase (303 homozygous
diploids + 469 heterozygous diploids). New cell size mutants: Statistical
analysis for cell size of the newly identified size mutants in Table 1. Size
mutant failures: Statistical analysis for cell size of the 14 mutants which
failed to repeat the size phenotypes. % Repeatability: Comparative cell
size analysis of the overlapping 144 newly constructed deletion strains
with the previous screens. Epistasis size values: Logarithmic phase
mean cell size readings for the epistatic combinations.
Additional file 2: Figure S1. Cell size analyses of yeast deletion strains.
(A) Total of 767 deletion strains (homozygous+heterozygous) were sized
in the logarithmic phase. Each data point represents the number of
strains whose size falls in a 5 fL bin. The two curves represent the
geometric mean (diamond) and median (square) of the cell sizes. Upper
and lower size limits are indicated by dashed lines and 95% of strains
had mean cell sizes within the range of 82.7fL and 118fL (±2SD of the
average mean cell size). WT mean cell size (104.1fL) is depicted by the
arrow. (B) Total of 772 deletion strains (homozygous+heterozygous) were
sized in the saturation phase. Each data point represents the number of
strains whose size falls in a 5 fL bin. The two curves represent the
geometric mean (diamond) and median (square) of the cell sizes. Upper
and lower size limits are indicated by dashed lines and 95% had mean
cell sizes within the range of 38.8fL and 62.8fL (±2SD of the average
mean cell size). WT mean cell size (48.8fL) is depicted by the arrow.
Additional file 3: Figure S2. Cell size distribution curves in saturation
phase. Geometric mean distribution curves are represented for the strainsstudied. Each data point represents the number of strains whose size falls
in a 5 fL bin. (A) Screen carried out in the year 2002 (Mean cell size =
50.8 fL). (B) Analysis of the new strains (Mean cell size = 50.8fL).
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